1.
Ter Arkh
; 91(2): 109-117, 2019 Mar 18.
Article
in English
| MEDLINE
| ID: mdl-31094181
ABSTRACT
The article presents an update of the role of non-alcoholic fatty liver disease (NAFLD) in cardiometabolic diseases and events: arterial hypertension and components of the metabolic syndrome. A review of NAFLD modern pharmacotherapy has been conducted. Particular attention is paid to the place of ursodeoxycholic acid in the complex treatment of NAFLD.
Subject(s)
Cholagogues and Choleretics/therapeutic use , Hypertension/complications , Metabolic Syndrome/complications , Non-alcoholic Fatty Liver Disease/drug therapy , Ursodeoxycholic Acid/therapeutic use , Humans , Non-alcoholic Fatty Liver Disease/complications , Risk Factors
2.
Klin Med (Mosk)
; 68(8): 92-3, 1990 Aug.
Article
in Russian
| MEDLINE
| ID: mdl-2084386